RT Book, Section
A1 Schrantz, Stephen
A1 Czapar, Anna
A1 Karmarkar, Ellora
A1 Lew, Allison
A1 MacKenzie, Erica
A1 Petit, Natasha
A2 Schmidt, Gregory A.
A2 Kress, John P.
A2 Douglas, Ivor S.
SR Print(0)
ID 1201805692
T1 Management of the Critically Ill Patient with HIV/AIDS
T2 Hall, Schmidt and Wood’s Principles of Critical Care, 5<sup>th</sup> Edition
YR 2023
FD 2023
PB McGraw Hill
PP New York, NY
SN 9781264264353
LK accesssurgery.mhmedical.com/content.aspx?aid=1201805692
RD 2024/10/14
AB KEY  POINTSCombination  antiretroviral  therapy  (cART)  has  been  shown  to  prolong  survival  and  disease-free  interval.  Interruption  in  adherence  to  treatment  is  a  major  risk  for  opportunistic  infections  (OIs)  leading  to  critical  care  needs.Because  of  better  treatment  and  prolonged  survival,  more  patients  are  admitted  to  the  ICU  who  have  HIV/AIDS  as  an  underlying  illness  as  opposed  to  the  cause  of  ICU  admission.Assessment  of  immunologic  functioning  via  measurement  of  CD4+  lymphocytes  is  fundamental  in  determining  risk  for  OIs.Continuation  or  initiation  of  cART  during  the  period  of  critical  illness  is  dependent  on  the  ability  to  tolerate  treatment  and  presence  or  absence  of  certain  OIs.  Presence  of  an  immune  reconstitution  inflammatory  syndrome  should  often  be  considered.Proper  diagnosis  of  OI  is  important  to  initiate  prompt  targeted  treatment.Recognition  of  the  social  aspects  of  the  patient’s  care  that  lead  to  critical  illness  is  important  to  reduce  re-admissions  and  complications  in  the  care  of  the  patient.